Treat CF as Deeply as They Live. Treat the cause with ORKAMBI®.

ORKAMBI is a breakthrough treatment for the underlying cause of cystic fibrosis (CF) in people with 2 copies of the F508del mutation. And that's pretty exciting.

ORKAMBI is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age 6 years and older who have two copies of the F508del mutation (F508del/F508del) in their CFTR gene.

ORKAMBI should not be used in patients other than those who have two copies of the F508del mutation in their CFTR gene.

It is not known if ORKAMBI is safe and effective in children under 6 years of age.